Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo

Completed · Phase 4 · Has a placebo group

Conditions studied: Healthy

In brief

This study is being performed as a Phase IV FDA commitment study and is being powered adequately to assess changes in sperm concentration, FSH and testosterone in healthy male subjects treated with pregabalin as compared to placebo, in addition to confirming lack of effects on sperm motility.

Key facts

Study ID
NCT00631696
Run by
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
People needed
222
Starts
2008-02-01
Expected to finish
2012-02-01
Last updated by the study team
2021-01-26

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.